Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBV Vaccination in Anti-HBc Positive Liver Transplant Recipients
NCT04442841Phase 2Unknown
- Sponsor
- Hospital Clínic de Barcelona
- Start
- Sep 2020
- Primary completion
- Jan 2022
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by Hospital Clínic de Barcelona. Primary endpoints: Response to HBV vaccine and Incidence of Emergent Adverse Events in case of nucleos(t)ide analogue (NUC) treatment interruption. Status: unknown.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT04442841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04442841.